|
Aug 11
|
Ironwood Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 8
|
IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates
|
|
Aug 7
|
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates
|
|
Aug 7
|
Ironwood: Q2 Earnings Snapshot
|
|
Aug 7
|
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance
|
|
May 8
|
IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates
|
|
May 7
|
Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 7
|
Ironwood: Q1 Earnings Snapshot
|
|
May 7
|
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
|
|
May 6
|
Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
|
|
Apr 1
|
Corcept (CORT) Stock Jumps 109.1%: Will It Continue to Soar?
|
|
Feb 20
|
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
|
|
Aug 29
|
Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
|
|
Jul 25
|
Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call
|
|
Jun 12
|
Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)
|
|
May 30
|
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
|
|
May 12
|
US$16.33: That's What Analysts Think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Is Worth After Its Latest Results
|
|
May 10
|
Ironwood Pharmaceuticals Reports Mixed Q1 2024 Results Amid Key Clinical Advancements
|
|
May 10
|
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
|